ProfileGDS4718 / 206642_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 15% 16% 5% 11% 4% 4% 7% 12% 13% 7% 7% 4% 2% 2% 6% 14% 6% 6% 6% 6% 12% 10% 13% 6% 5% 5% 14% 10% 9% 5% 6% 7% 13% 14% 9% 7% 4% 7% 9% 6% 4% 5% 6% 4% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.9552915
GSM549102patient 115, normal, homogenized [OPG study]3.9992816
GSM549104patient 119, normal, homogenized [OPG study]3.536985
GSM549108patient 138, normal, homogenized [OPG study]3.847111
GSM549119patient 077, normal, homogenized [OPG study]3.546564
GSM549133patient 032, cancer, homogenized [OPG study]3.495664
GSM549139patient 042, cancer, homogenized [OPG study]3.633937
GSM549099patient 107, normal, homogenized [OPG study]3.8750312
GSM549109patient 139, normal, homogenized [OPG study]3.9257713
GSM549110patient 046, normal, homogenized [OPG study]3.661997
GSM549114patient 063, normal, homogenized [OPG study]3.638137
GSM549122patient 082, normal, homogenized [OPG study]3.547354
GSM549134patient 033, cancer, homogenized [OPG study]3.439132
GSM549136patient 036, cancer, homogenized [OPG study]3.41072
GSM549140patient 044, cancer, homogenized [OPG study]3.593736
GSM549111patient 047, normal, homogenized [OPG study]3.8901814
GSM549113patient 057, normal, homogenized [OPG study]3.595176
GSM549132patient 031, cancer, homogenized [OPG study]3.637216
GSM549137patient 038, cancer, homogenized [OPG study]3.623376
GSM549142patient 047, cancer, homogenized [OPG study]3.672616
GSM549100patient 110, normal, homogenized [OPG study]3.8386712
GSM549107patient 135, normal, homogenized [OPG study]3.7441910
GSM549115patient 068, normal, homogenized [OPG study]3.8441613
GSM549116patient 072, normal, homogenized [OPG study]3.614876
GSM549120patient 078, normal, homogenized [OPG study]3.581955
GSM549131patient 030, cancer, homogenized [OPG study]3.548235
GSM549118patient 074, normal, homogenized [OPG study]3.9115814
GSM549129patient 027, cancer, homogenized [OPG study]3.7903910
GSM549123patient 088, normal, homogenized [OPG study]3.752789
GSM549124patient 006, cancer, homogenized [OPG study]3.600025
GSM549126patient 015, cancer, homogenized [OPG study]3.608146
GSM549128patient 025, cancer, homogenized [OPG study]3.635417
GSM549103patient 117, normal, homogenized [OPG study]3.9113713
GSM549117patient 073, normal, homogenized [OPG study]3.9370614
GSM549138patient 041, cancer, homogenized [OPG study]3.727319
GSM549141patient 045, cancer, homogenized [OPG study]3.628767
GSM549130patient 028, cancer, homogenized [OPG study]3.559314
GSM549101patient 111, normal, homogenized [OPG study]3.642197
GSM549105patient 128, normal, homogenized [OPG study]3.762829
GSM549106patient 134, normal, homogenized [OPG study]3.603246
GSM549112patient 048, normal, homogenized [OPG study]3.543814
GSM549125patient 011, cancer, homogenized [OPG study]3.591685
GSM549127patient 024, cancer, homogenized [OPG study]3.60196
GSM549135patient 035, cancer, homogenized [OPG study]3.499384